MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
Objective: To assess the safety and immunogenicity of the MF59-adjuvanted seasonal trivalent inactivated influenza vaccine (aIIV3; Fluad) in children aged 6 months through 5 years who are at risk of influenza complications. Methods: A retrospective analysis was performed to examine unsolicited adver...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2019-08-01
|
| Seri Bilgileri: | International Journal of Infectious Diseases |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1201971219301948 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|